methicillin-resistant Staph aureus (MRSA) infections in hospitalized patients

New guidelines will clarify treatment of methicillin-resistant Staph aureus (MRSA) infections in hospitalized patients.

Recommend choosing treatments based on the infection site, patient's age, antibiotic sensitivities, patient tolerance, cost, etc.

Keep in mind that the newer drugs (daptomycin, linezolid) cost much more than the older ones (clindamycin, TMP/SMX, vancomycin).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote